FundedIQ
Biotechnology

Evoq Therapeutics: Funding, Investors & Team (Oct 2026)

Evoq Therapeutics is a company which specializes in cancer immunotherapy and offers immune modulating treatments for patients with autoimmune diseases. Their technology involves using a unique NanoDisc to deliver antigens in order to restore immune tolerance.

www.evoqtherapeutics.com LinkedIn Ann Arbor, United States 1-10 employees
Biopharma Biotechnology Health Care Life Science Medical B2B
Total raised
$2.0M
Rounds
1
Latest
Undisclosed round
Aug 2024

Evoq Therapeutics has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Aug 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Evoq Therapeutics Company Profile and Key Stats

Total funding raised
$2.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.0M in Aug 2024
Employees
1-10
reported band
Headquarters
Ann Arbor, United States

Latest funding round on record: Aug 2024.

Evoq Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$2.0M

Evoq Therapeutics Founders and Leadership Team

Name
Role
Contact
William Brinkerhoff
Founder
Locked

Contact details for the Evoq Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Evoq Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Evoq Therapeutics' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Evoq Therapeutics in Biotechnology and Ann Arbor

Companies Similar to Evoq Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Evoq Therapeutics Funding FAQs

What does Evoq Therapeutics do?

Evoq Therapeutics is a company which specializes in cancer immunotherapy and offers immune modulating treatments for patients with autoimmune diseases. Their technology involves using a unique NanoDisc to deliver antigens in order to restore immune tolerance.

How much funding has Evoq Therapeutics raised?

Evoq Therapeutics has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Aug 2024.

When did Evoq Therapeutics last raise funding?

Evoq Therapeutics' most recent funding round on record is an undisclosed round of $2.0M, announced in Aug 2024.

Who founded Evoq Therapeutics?

FundedIQ lists William Brinkerhoff (Founder) at Evoq Therapeutics.

Where is Evoq Therapeutics headquartered?

Evoq Therapeutics is based in Ann Arbor, Michigan, United States.

How many employees does Evoq Therapeutics have?

Evoq Therapeutics is in the 1-10 employee band.

How does Evoq Therapeutics' funding compare to other Biotechnology startups?

Evoq Therapeutics' latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Evoq Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evoq Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.